Molecular model of Imatinib (C29 H31 N7 O). Imatinib is part of a new class of drugs used in the treatment of chronic myelogenous leukaemia (CML),gastrointestinal stromal tumours (GIST) and a number of other malignancies. It acts by specifically inhibiting an enzyme (a receptor tyrosine kinase) that is characteristic of a particular cancer cell,rather than non-specifically inhibiting and killing all rapidly dividing cells. Carbon in grey; Hydrogen in yellow; Nitrogen in blue; Oxygen in red. Mol. mass: 493.603 g/mol | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / SciMAT |
Taille de l’image : | 2892 px × 2472 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : |
|